---
title: "Humacyte submits Biologics License Application to US FDA seeking approval of Human Acellular Vessel for the treatment of vascular trauma"
date: "2023-12-12T17:08:37.000Z"
publishedDate: "12 décembre 2023"
summary: "Humacyte today announced that it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) seeking approval of the Human Acellular Vessel (HAV) in urgent arterial repair following extremity vascular trauma when synthetic graft is not indicated, and when autologous vein use is not feasible. A press release details that [&#8230;] The post Humacyte submits Biologics License Application to US FDA seeking approval of Human Acellular Vessel for the treatment of vascular trauma appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/humacyte-submits-biologics-license-application-to-us-fda-seeking-approval-of-human-acellular-vessel-for-the-treatment-of-vascular-trauma/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-12-12-humacyte-submits-biologics-license-application-to-us-fda-seeking-approval-of-human-acellular-vessel-for-the-treatment-of-vascular-trauma"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/humacyte-submits-biologics-license-application-to-us-fda-seeking-approval-of-human-acellular-vessel-for-the-treatment-of-vascular-trauma/"
---

![Humacyte submits Biologics License Application to US FDA seeking approval of Human Acellular Vessel for the treatment of vascular trauma](https://vascularnews.com/wp-content/uploads/sites/7/2023/08/Humacyte-HAV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/humacyte-submits-biologics-license-application-to-us-fda-seeking-approval-of-human-acellular-vessel-for-the-treatment-of-vascular-trauma/*

## L’essentiel

Humacyte today announced that it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) seeking approval of the Human Acellular Vessel (HAV) in urgent arterial repair following extremity vascular trauma when synthetic graft is not indicated, and when autologous vein use is not feasible. A press release details that [&#8230;] The post Humacyte submits Biologics License Application to US FDA seeking approval of Human Acellular Vessel for the treatment of vascular trauma appeared first on Vascular News .

## Lien source

https://vascularnews.com/humacyte-submits-biologics-license-application-to-us-fda-seeking-approval-of-human-acellular-vessel-for-the-treatment-of-vascular-trauma/
